Milton C. Ault III - Feb 15, 2023 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
10%+ Owner
Signature
/s/ Milton C. Ault, III
Stock symbol
ALZN
Transactions as of
Feb 15, 2023
Transactions value $
$597
Form type
4
Date filed
2/17/2023, 08:55 PM
Previous filing
Feb 13, 2023
Next filing
Mar 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Purchase $597 +1K +0.01% $0.60 11.1M Feb 15, 2023 By Ault Lending, LLC F1
holding ALZN Common Stock 2.5M Feb 15, 2023 Direct
holding ALZN Common Stock 365K Feb 15, 2023 By Ault Alpha LP F2
holding ALZN Common Stock 14.9M Feb 15, 2023 By Ault Life Sciences, Inc. F3
holding ALZN Common Stock 10M Feb 15, 2023 By Ault Life Sciences Fund, LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AA"). Mr. Ault, the Executive Chairman of AA, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F2 Milton C. Ault, III, is the Manager of Ault Alpha GP LLC ("Ault GP") and Ault Capital Management LLC ("AC Management"). Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP.
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F4 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.